Marcho Partners’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-861,699
Closed -$1.08M 25
2021
Q1
$1.08M Buy
+861,699
New +$1.23M 0.09% 25

Other funds holding CPUH.WS

Marcho Partners's CPUH.WS Position: Q2 2021 in Review

Marcho Partners sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q2 2021, closing a stake of 861,699 shares — an estimated $1.08M sold.

Marcho Partners first reported a position in CPUH.WS in Q1 2021 and held it in 1 quarter. The position peaked at $1.08M in Q1 2021. 54 funds tracked by Wall St. Rank hold CPUH.WS as of Q2 2021.

  • Marcho Partners reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q2 2021 after selling out during the quarter.
  • Marcho Partners sold 861,699 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q2 2021, an estimated $1.08M.
  • Marcho Partners first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2021 and held it in 1 quarter.
  • Marcho Partners's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $1.08M in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q2 2021.

Based on Marcho Partners's 13F filing for Q2 2021, filed 12 Aug 2021.